Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection can trigger
the adaptive and innate immune responses, leading to uncontrolled inflammatory reactions …

Abstract Coronavirus disease 2019 (COVID-19) is a recent pandemic caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) leading to pulmonary and …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection leads to
hyper-inflammation and amplified immune response in severe cases that may progress to …

Abstract Coronavirus disease 19 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome 2 (SARS-CoV-2). Throughout the pandemic, evidence on the …

Abstract Coronavirus disease 2019 (Covid‐19) is caused by a novel severe acute
respiratory syndrome coronavirus virus type 2 (SARS‐CoV‐2) leading to the global …

Abstract Coronavirus disease 2019 (COVID‐19) is a novel pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has been shown that SARS …

Dantrolene (DTN) is a ryanodine receptor (RyR) antagonist that inhibits Ca2+ release from
stores in the sarcoplasmic reticulum. DTN is mainly used in the management of malignant …

COVID‐19 is caused by a novel SARS‐CoV‐2 leading to pulmonary and extra‐pulmonary
manifestations due to oxidative stress (OS) development and hyperinflammation. COVID‐19 …

ABSTRACT Coronavirus disease 2019 (Covid-19) is a recent and current infectious
pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …